Symbols

Symbols

CLNN

CLNN

Clene shares rise 11.92% intraday as CEO outlines Q1 2026 NDA plans for CNM-Au8 and regulatory progress.

Thursday Nov 13, 2025

Clene shares surge 11.71% after hours on FDA meeting and NDA plan for ALS therapy.

Clene Biopharma Reports Q3 Net Loss of $8.8mln, Focused on Mitochondrial Health and Neurodegenerative Diseases Treatment

Clene to submit ALS NDA in Q1 2026, phase 3 trial to start H1 2026.

Clene concludes ALS biomarker data, plans NDA submission in Q1 2026.

Wednesday Nov 12, 2025

Clene's 15min chart triggers KDJ Death Cross, bearish Marubozu pattern detected.

Clene's 15-minute chart sees MACD Death Cross and Bearish Marubozu signals.

Clene shares surge 20.42% premarket on JonesTrading buy rating for CNM-Au8 driven by promising ALS results.

Tuesday Nov 11, 2025

Clene's 15-Minute Chart Displays MACD & KDJ Death Crosses

Clene's 15min chart triggers KDJ Death Cross, bearish Marubozu pattern detected.

Tuesday Nov 04, 2025

Clene's 15min MACD Death Cross and Bearish Marubozu Signal Bearish Trend

Monday Nov 03, 2025

Electromed's 15min chart shows KDJ Golden Cross and Bullish Marubozu signals.

Clene's 15min chart triggers MACD Death Cross, KDJ Death Cross

Clene's 15min Chart Shows RSI Overbought and KDJ Death Cross.

Tuesday Oct 28, 2025

Clene's 15min chart triggers KDJ Death Cross, bearish Marubozu formation.

Monday Oct 27, 2025

Clene's 15min chart triggers KDJ Death Cross, bearish Marubozu formation.

Clene's 15min chart shows MACD Death Cross and Bearish Marubozu signal.

Clene's 15min chart triggers KDJ Death Cross, bearish Marubozu formation.

Friday Oct 24, 2025

Clene's 15-Minute Chart Displays KDJ Golden Cross and Bullish Marubozu

Monday Oct 20, 2025

Clene to Present at Emerging Growth Conference, October 23, 2025.